# ONEMEDNET CORPORATION (ONMD) · Edgar & Edgarette company card

> Onemednet (ONMD) grew revenue 111% in FY2025 to $1 million, operating margin -711% against a 14.9% median for commercial physical & biological research, equity -138% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1849380 · fiscal year ended 2025-12-31 · 4 audited years read · [page](https://www.pops4.com/boards/company/ONMD) · [JSON](https://www.pops4.com/boards/company/ONMD.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $1M |
| Revenue growth, 1 year | 111.4% |
| Revenue growth per year | 5.6% |
| Operating margin | -711.3% (prior year -1493.8%) |
| Net margin | -206.1% |
| Operating cash flow | −$8M |
| Capital spending | $13,000 |
| Free cash flow | −$8M |
| Cash | $585,000 |
| Long-term debt | $220,000 |
| Total assets | $2M |
| Total equity | −$3M |
| Equity ÷ assets | -137.8% |
| Return on equity | — |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -197.32 (distress zone)
- Piotroski F: 5 of 9 (middling)
- Health Harbor boat: Rotting at the dock · four or more warning signs · liabilities exceed assets (often from years of share buybacks, not always distress); operating cash flow was negative; operating loss: a margin of -711.3% in FY2025; revenue is hard to predict: its 80% range is ±71%
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $1.4M (FY2025), total debt $220K. Experience: revenue up 111.4% on the year, up 5.6% a year over 3 years; operating margin -711.3%, up from -1493.8%. Soundness: equity -137.8% of assets (liabilities exceed assets). Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $869K and $5.2M next year (method v4.1: its own 3-year record of growth weighed at 40% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $768K to $5.9M. A statistical range, not company guidance. Against peers (8 filers, $50M+ revenue, its industry group): operating margin -711.3% against a 14.9% median; growth 111.4% against 5.2%.

Range logged 2026-09-24, receipt a5825e50eb427862, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 1, latest 2026-04-20 ([filing](https://www.sec.gov/Archives/edgar/data/1849380/000149315226018129/0001493152-26-018129-index.htm))
- Item 5.02 Director or officer change: 1, latest 2026-09-23 ([filing](https://www.sec.gov/Archives/edgar/data/1849380/000149315226043943/0001493152-26-043943-index.htm))

## Recent filings

- 8-K · filed 2026-11-06 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1849380/000149315226050362/0001493152-26-050362-index.htm)
- 8-K · filed 2026-10-14 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1849380/000149315226046931/0001493152-26-046931-index.htm)
- 8-K · filed 2026-09-29 · 3.03 Material Modifications to Rights of Security Holders; 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1849380/000149315226044801/0001493152-26-044801-index.htm)
- 8-K · filed 2026-09-23 · 5.02 Departure or Election of Directors; Appointment of Officers; 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1849380/000149315226043943/0001493152-26-043943-index.htm)
- DEF 14A · filed 2026-08-19 · [filing](https://www.sec.gov/Archives/edgar/data/1849380/000149315226039206/0001493152-26-039206-index.htm)
- 10-Q · filed 2026-08-14 · [filing](https://www.sec.gov/Archives/edgar/data/1849380/000149315226038461/0001493152-26-038461-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001849380.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1849380

## Cite

POPS4, Edgar & Edgarette: ONEMEDNET CORPORATION (ONMD) company card, from the company's own SEC filings, accessed 2026-11-08, https://www.pops4.com/boards/company/ONMD. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.